Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Acta Pharmacol Sin ; 43(12): 3080-3095, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36114271

RESUMO

Traditional medicine has provided a basis for health care and disease treatment to Chinese people for millennia, and herbal medicines are regulated as drug products in China. Chinese herbal medicines have two features. They normally possess very complex chemical composition. This makes the identification of the constituents that are together responsible for the therapeutic action of an herbal medicine challenging, because how to select compounds from an herbal medicine for pharmacodynamic study has been a big hurdle in such identification efforts. To this end, a multi-compound pharmacokinetic approach was established to identify potentially important compounds (bioavailable at the action loci with significant exposure levels after dosing an herbal medicine) and to characterize their pharmacokinetics and disposition. Another feature of Chinese herbal medicines is their typical use as or in combination therapies. Coadministration of complex natural products and conventional synthetic drugs is prevalent worldwide, even though it remains very controversial. Natural product-drug interactions have raised wide concerns about reduced drug efficacy or safety. However, growing evidence shows that incorporating Chinese herbal medicines into synthetic drug-based therapies delivers benefits in the treatment of many multifactorial diseases. To address this issue, a drug-combination pharmacokinetic approach was established to assess drug-drug interaction potential of herbal medicines and degree of pharmacokinetic compatibility for multi-herb combination and herbal medicine-synthetic drug combination therapies. In this review we describe the methodology, techniques, requirements, and applications of multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines and to discuss further development for these two types of pharmacokinetic research.


Assuntos
Medicamentos de Ervas Chinesas , Plantas Medicinais , Humanos , Medicamentos de Ervas Chinesas/farmacologia , Plantas Medicinais/química , Medicina Tradicional Chinesa , Combinação de Medicamentos , Interações Medicamentosas
2.
Acta Pharmaceutica Sinica ; (12): 2426-2446, 2021.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-886965

RESUMO

Chinese traditional medicine has provided, since ancient times, a basis for health care and medicine to the Chinese nation and for China's national stability. Identification of the constituents responsible for therapeutic and undesired effects of Chinese herbal medicines is a type of key research facilitating the modernization of these medicines. For a complex Chinese herbal medicine, multi-compound pharmacokinetic research is a useful approach to identifying its constituents that are bioavailable (in their unchanged and/or metabolized forms) at loci responsible for the medicine's therapeutic action and to characterizing the compounds' disposition and pharmacokinetics related to the action. In addition, such pharmacokinetic research is also useful for identifying herbal compounds associated with the medicine's adverse effects and drug-drug interaction potential. Over the past decade, great advances have been achieved in the theory, methodology, associated techniques, and their application of such multi-compound pharmacokinetic research, which has become an emerging field in pharmacokinetics. In this perspective, we elaborate on the methodology, technical requirements, and key analytical techniques of multi-compound pharmacokinetic research on Chinese herbal medicines, describe research examples regarding investigation of pharmacokinetics and disposition of a class of bioactive herbal constituents (ginsenosides of Panax notoginseng root) and pharmacokinetics-based identification of potential therapeutic compounds from a dosed Chinese herbal medicine (LianhuaQingwen capsule), and discuss follow-up development for the multi-compound pharmacokinetic research.

3.
Zhongguo Zhong Yao Za Zhi ; 42(4): 607-617, 2017 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-28959826

RESUMO

There are two prerequisites for the therapeutic action of a drug, i.e., having sufficient bioavailability to and biopersistence at the locus of action after dosing and having intrinsic ability to produce desired pharmacodynamic effects in their major exposure forms, unchanged and metabolized. As a special branch of pharmacology of Chinese herbal medicines, pharmacokinetics is to investigate issues related to the medicines' efficacy and safety by assessing the herbal ingredients' bioavailability to and biopersistence at the locus of action in the body. Chinese herbal medicines are often herb combinations of complex mixture and contain multiple bioactive ingredients working in concert. Unlike most investigational synthetic drugs developed from bench to bedside, Chinese herbal medicines are often developed from bedside to bench to bedside. Accordingly, pharmacokinetic research on Chinese herbal medicines could serve as a crucial step in identifying the chemical basis of the medicines' therapeutic actions and could facilitate development of new herbal medicines with enhanced efficacy and safety by using the right herbal ingredients in the right way. Mainly based on studies by the author's research group, this article illustrates approach to and methodology of multi-compound pharmacokinetic research on Chinese herbal medicines.


Assuntos
Pesquisa Biomédica , Medicamentos de Ervas Chinesas/farmacocinética , Plantas Medicinais , Disponibilidade Biológica , Humanos
4.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-275489

RESUMO

There are two prerequisites for the therapeutic action of a drug, i.e., having sufficient bioavailability to and biopersistence at the locus of action after dosing and having intrinsic ability to produce desired pharmacodynamic effects in their major exposure forms, unchanged and metabolized. As a special branch of pharmacology of Chinese herbal medicines, pharmacokinetics is to investigate issues related to the medicines' efficacy and safety by assessing the herbal ingredients' bioavailability to and biopersistence at the locus of action in the body. Chinese herbal medicines are often herb combinations of complex mixture and contain multiple bioactive ingredients working in concert. Unlike most investigational synthetic drugs developed from bench to bedside, Chinese herbal medicines are often developed from bedside to bench to bedside. Accordingly, pharmacokinetic research on Chinese herbal medicines could serve as a crucial step in identifying the chemical basis of the medicines' therapeutic actions and could facilitate development of new herbal medicines with enhanced efficacy and safety by using the right herbal ingredients in the right way. Mainly based on studies by the author's research group, this article illustrates approach to and methodology of multi-compound pharmacokinetic research on Chinese herbal medicines.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...